Helps therapy now has equipment that prolong the lives of people contaminated with the virus and stop others from acquiring it. They range between antiretroviral therapy , to promotions and circumcision to reduce promiscuity. On the horizon are gels and supplements that protect against infection during intercourse. Even the outlook for an Helps vaccine is no longer as bleak as it used to be. On June 5 Helps first found public attention, 1981 in a report on a uncommon kind of pneumonia in five gay men, but scientists today believe the virus entered human beings early in the 20th hundred years.Based on the American Cancer Culture, it is estimated that ovarian tumor will be diagnosed in about 22,000 ladies in the U.S. This full year and 80 % of cases are not detected until the cancer has spread. That in place means a lot more than 16,000 U.S. Ladies shall die of ovarian cancer in 2005. The report is released in the Archives of Internal Medicine.
ADDF awards Yuma $249,810 grant for Alzheimer’s research The Alzheimer’s Drug Discovery Basis announced today that it has awarded a grant of $249,810 to Yuma Therapeutics Corporation to build up small molecules to treat Alzheimer’s disease. The award will fund work to develop Yuma’s innovative disease-modifying pharmaceutical substances that target neurofibrillary tangles resulting from abnormal forms of the proteins tau, which represents a promising fresh approach with potential to affect disease progression in Alzheimer’s disease.